Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry does not describe a single molecular target but rather a broad mechanism of action involving the non-specific degradation of cellular macromolecules—including proteins, lipids, and nucleic acids—mediated by reactive oxygen species (ROS), reactive nitrogen species (RNS), and acidic environments. In biological systems, ROS and RNS are highly reactive molecules that cause oxidative and nitrosative stress, leading to DNA strand breaks, lipid peroxidation, and protein carbonylation (Source: NIH/NCBI, 'Reactive Oxygen Species and Antioxidant Defense'). Certain therapeutic agents, such as methenamine, rely on a low pH environment to undergo hydrolysis into active antimicrobial components like formaldehyde, which then non-specifically denatures bacterial proteins (Source: StatPearls, 'Methenamine'). Similarly, antiseptics and certain chemotherapeutics generate an oxidative burst to overwhelm cellular repair mechanisms, a process also utilized by macrophages during the innate immune response. Because this 'target' encompasses nearly all structural and functional components of a cell, it is typically associated with non-specific cytotoxic effects rather than high-affinity drug-receptor interactions. Consequently, while effective for broad-spectrum antimicrobial or localized antineoplastic activity, these mechanisms pose significant challenges regarding systemic toxicity and the protection of healthy host tissues.
Non-specific chemical modification (oxidation, nitration, or hydrolysis) of proteins, lipids, and nucleic acids leading to loss of structural integrity and cellular function.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Broad cellular components (via reactive oxygen species, reactive nitrogen species, and low pH).